Congenital fetal goiter is a very rare pathology, is sometimes difficult to diagnose when there is no maternal history or the goiter size is moderate. We report a case of prenatally diagnosed fetal goiter in a euthyroid mother. A 28-year-old woman was referred to our clinic at 38 +2 weeks of gestation. Ultrasonographic examination revealed a fetal goiter. The maternal history and thyroid function tests, including antithyroid autoantibody tests, were unremarkable. Cesarean section was performed, and the thyroid profile of the neonate was consistent with congenital hypothyroidism. Thyroxine therapy was immediately started. Fetal thyroid function must be determined when a goiter is detected. Cordocentesis is a more reliable but riskier diagnostic tool than amniocentesis. Intra-amniotic injection of thyroxine is relatively safe and an easier management option for fetal hypothyroidism. To develop more noninvasive and safe methods for therapeutic efficacy monitoring, a large-scale study is necessary.
the consequences of undiagnosed impaired fetal thyroid function are serious. Fetal hypothyroidism is associated with mental retardation and delayed bone maturation. 2, 3 Hyperthyroidism is also dangerous, with an increased spontaneous abortion rate due to fetal cardiac failure. Goiter itself, may also result in dystocia or neonatal airway obstruction due to its mass effect. 4, 5 Therefore, fetal thyroid function must be determined when a goiter is detected.
We report a prenatally diagnosed case of fetal goi ter in a euthyroid mother, and review crucial points in the management of fetal thyroid disease. and thyroid growth rate can be used for the evaluation of the fetal thyroid state. 9 Color Doppler is also helpful in detecting the fetal thyroid. 10 Fetal thyroid status can be diagnosed via amnio centesis or cordocentesis. Amniocentesis is useful for the TSH level. However, many studies have expressed doubt about its reliability because amniotic fluid thyroid hormone levels do not accurately reflect fetal hormonal status. 11 Cordocentesis is a more reliable diagnostic tool, but riskier, with a fetal bleeding or loss rate of about 0.51%. 12 Management of fetal hyperthyroidism is relatively simpler, via maternal administration of propylthiouracil (PTU). In contrast, fetal hypothyroidism cannot be treated by maternal thyroxine administration because thyroxine cannot pass through the placenta. The only treatment method is injection of thyroxine into fetal muscle or a blood vessel, or into the amniotic fluid.
Case Report
Injection into the fetus itself risks injury and may require several puncture attempts. Intraamniotic injection of thyroxine is a relatively safer and simpler management option than other methods, and has a long treatment interval. Accordingly, in recent years, intraamniotic injection of thyroxine has been the most common therapeutic option for congenital hypo thyroidism. 3, 13, 14 Recent study summarized the in utero treatment of fetal goitrous hypothyroidism data in their report. 15 Repeated cordocentesis is hazardous; therefore, monitoring therapeutic efficacy is a matter of con cern. 16 Studies suggest that serial ultrasonographic monitoring of fetal goiter size is helpful. 10 Studies on the thyroid vascular pattern using color Doppler are under investigation. A vanishing or diminishing Doppler signal and fetal heart rate variability pattern were suggested to reflect improvement in thyroid function, but a largescale study is necessary to con firm this. 10, 17, 18 To the best of our knowledge, this is the first re port about fetal goiter in a euthyroid mother. In our case, there was no polyhydroamnios or fetal neck hyperextension and the size of fetal goiter was not remarkable. Main diagnostic clue was Color Doppler findings with peripheral blood flow flushing of fetal thyroid. Our case was diagnosed in late pregnancy leaving no time for management. Therefore, we decided on immediate delivery rather than attempting a risky invasive procedure. Although in utero treat ment was impossible, our prenatal diagnosis was helpful for immediate postnatal therapy.
In conclusion, even though fetal goiter accompanied by congenital hypothyroidism is a rare disorder, es pecially in a euthyroid mother, the thyroid must be evaluated during antenatal evaluation. In early pregnancy, in utero evaluation and management is essential, and requires careful and experienced hands.
In late pregnancy, postnatal evaluation after should also be considered. Color Doppler will be helpful for initial diagnosis of fetal thyroid disease and monitoring.
A largescale study is necessary for monitoring therapeutic efficacy and longterm prognosis.
